about
Hospital capacity during an influenza pandemic-Buenos Aires, Argentina, 2009.Data for decision making: strategic information tools for hospital management during a pandemic.Transmission of 2009 pandemic influenza A (H1N1) virus among healthcare personnel-Southern California, 2009.Neglected parasitic infections in the United States: trichomoniasis.Trichomoniasis: the "neglected" sexually transmitted disease.Ebola RNA Persistence in Semen of Ebola Virus Disease Survivors - Preliminary Report.A Review of Evidence-Based Care of Symptomatic Trichomoniasis and Asymptomatic Trichomonas vaginalis InfectionsTrichomonas vaginalis in selected U.S. sexually transmitted disease clinics: testing, screening, and prevalenceHPV vaccine coverage among men who have sex with men - National HIV Behavioral Surveillance System, United States, 2011Health care use and opportunities for human papillomavirus vaccination among young men who have sex with men.Can clinical tests help monitor human papillomavirus vaccine impact?A Trich-y question: should Trichomonas vaginalis infection be reportable?Sexually transmitted infections among US women and men: prevalence and incidence estimates, 2008.Cervical Cancer Screening and Prevention in 78 Sexually Transmitted Disease Clinics-United States, 2014-2015.Clinical Inquiries Received by CDC Regarding Suspected Ebola Virus Disease in Children--United States, July 9, 2014-January 4, 2015.Human Papillomavirus Vaccination Among Young Men Who Have Sex With Men and Transgender Women in 2 US Cities, 2012-2014.Sexually Transmitted Disease Testing and Uptake of Human Papillomavirus Vaccine in a Large Online Survey of US Men Who Have Sex With Men at Risk for HIV Infection, 2012.Monitoring for Human Papillomavirus Vaccine Impact Among Gay, Bisexual, and Other Men Who Have Sex With Men-United States, 2012-2014.Preparing health care workers for a cholera epidemic, Dominican Republic, 2010.Fatal Clostridium sordellii infections after medical abortions.Two vs Three Doses of Human Papillomavirus Vaccine: New Policy for the Second Decade of the Vaccination Program.A student-initiated interactive course as a model for teaching reproductive health.HPV vaccine implementation in STD clinics--STD Surveillance Network.Chronic figurate skin lesions. Tinea imbricata.Severe methicillin-susceptible Staphylococcus aureus infections associated with epidural injections at an outpatient pain clinic.Human papillomavirus vaccination coverage using two-dose or three-dose schedule criteria.Use of a 2-Dose Schedule for Human Papillomavirus Vaccination-Updated Recommendations of the Advisory Committee on Immunization Practices.Sexually Transmitted Diseases Among Pregnant Women: 5 States, United States, 2009-2011.Ambulance Need at Mass GatheringsInvestigation of Increased Rates of Isolation of Bacillus SpeciesOpiate Exposure in Breastfeeding NewbornsUpdated medical care cost estimates for HPV-associated cancers: implications for cost-effectiveness analyses of HPV vaccination in the United StatesCost-effectiveness of nonavalent HPV vaccination among males aged 22 through 26 years in the United StatesDisclosure of Sexual Behavior Is Significantly Associated With Receiving a Panel of Health Care Services Recommended for Men Who Have Sex With MenTransgender Women Have Higher Human Papillomavirus Prevalence Than Men Who Have Sex With Men-Two U.S. Cities, 2012-2014HPV Vaccine Delivery Practices by Primary Care PhysiciansPrimary care physician support for harmonizing HPV vaccination recommendations across genders - United States, 2018Human Papillomavirus Vaccination for Adults: Updated Recommendations of the Advisory Committee on Immunization PracticesUse of a 2-Dose Schedule for Human Papillomavirus Vaccination - Updated Recommendations of the Advisory Committee on Immunization Practices
P50
Q30226893-B0BC63B1-D59B-411C-AB2D-A9F741BA2D69Q30397270-87AC0870-751E-4332-9FA8-FD27820665DEQ30409442-F9909E68-8DAB-4C42-81CE-8D5CCBBAC44AQ33588454-D6C51949-736D-4FEB-B60A-F96BE4A7751AQ34387759-2087461F-92FC-4876-AA40-B9A0920231BEQ34497945-E7AAE6DA-36BC-4333-8BB2-5A87B4FB0BA2Q36311615-44D779B7-0CC3-4118-8C19-8836C8F75E18Q36368342-03CD5166-F61C-4272-B527-147D330BBF9AQ36368353-604D61DF-2461-496A-89BA-E7E2D01992FEQ36380403-0F6BFCDF-B3D8-41F7-B3DD-729BD64C4265Q36407727-594DD15A-EDBC-478F-B565-20F58D97A204Q37258376-7287E50C-8754-41A8-BFF6-1D83B7BD16DDQ37847102-3CCD79DF-7EE1-4982-8C44-CACA7621CEBBQ40056088-1913C3B6-8308-4334-B4E6-94DA05A6B317Q40138420-A6445FA1-DBFC-476E-A5D9-2C5731377C33Q40162071-F6572E9B-7416-4A68-AA30-E299AA0FA962Q40431292-28B3448A-41D3-4D8C-AC9E-548BDB759E5EQ40703383-91DAB092-7E2C-4DA1-943E-8C970C25BCCBQ42572446-7A99CD2B-BDBB-41E2-86AF-ADCC94664ED9Q42873714-1E7069C5-143B-470C-8C28-0CAEB0D6ABB6Q43171949-85FCA59F-D723-4E9A-8A69-4FF9BD28498BQ43525270-99ABB98D-71AB-4429-A053-A6292354282EQ45951531-9CD94B26-A71B-4853-BE40-2F131A02F9ACQ46070435-1DB24A06-0CDE-4B9D-8DA3-B12A35EF7870Q46703450-0A8E833E-8AFE-46E5-8B5B-3E2C5E8E48D5Q47777631-ACF0D085-7E75-4938-9062-6B9D39349927Q47874062-2A17080B-1051-4524-BCD4-90D022A079F9Q50126063-F94469ED-D2A5-4AF0-938A-EF1C0223712CQ56973100-09A14C5C-C532-4741-93AF-29B7E5B1E69AQ56973111-B7273A7D-82BA-49B4-AE2A-5953214655F4Q56973121-F64F0522-B464-423E-8800-93543609A695Q64124111-440FF985-8F65-4A5B-A7B1-069EDEF2C221Q64137462-F6A54D3F-D917-486B-AB14-146DFBF5EB0DQ89259166-4405EE6A-73DC-40AF-BCA3-632FB915D6F3Q90092354-4FEAE627-EEAC-496E-99F9-AEA48F87E9C2Q90131809-3385C21E-13F2-4AA0-BCFA-110342E88F91Q91814501-A5260FBC-0759-46A8-AF9A-526F2DA004A9Q92637971-8C93DB80-45F6-41C7-89F4-6EB0C98E8944Q95784494-99852F57-C9A7-4027-98D7-12696896B982
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Elissa Meites
@ast
Elissa Meites
@en
Elissa Meites
@es
Elissa Meites
@nl
Elissa Meites
@sl
type
label
Elissa Meites
@ast
Elissa Meites
@en
Elissa Meites
@es
Elissa Meites
@nl
Elissa Meites
@sl
prefLabel
Elissa Meites
@ast
Elissa Meites
@en
Elissa Meites
@es
Elissa Meites
@nl
Elissa Meites
@sl
P106
P1153
6506865999
P21
P31
P496
0000-0002-0077-2591